Toxicity of IgA anti-CD3 isotype switch variant in vivo. 1994

I J ten Berge, and K J Parlevliet, and S L Yong, and J Surachno, and J M Wilmink, and P T Schellekens
Renal Transplant Unit, Academic Medical Center, University of Amsterdam, The Netherlands.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007132 Immunoglobulin Isotypes The classes of immunoglobulins found in any species of animal. In man there are nine classes that migrate in five different groups in electrophoresis; they each consist of two light and two heavy protein chains, and each group has distinguishing structural and functional properties. Antibody Class,Ig Isotype,Ig Isotypes,Immunoglobulin Class,Immunoglobulin Isotype,Antibody Classes,Immunoglobulin Classes,Class, Antibody,Class, Immunoglobulin,Classes, Antibody,Classes, Immunoglobulin,Isotype, Ig,Isotype, Immunoglobulin,Isotypes, Ig,Isotypes, Immunoglobulin
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D011398 Promethazine A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals. Proazamine,Atosil,Diphergan,Diprazin,Isopromethazine,Phenargan,Phenergan,Phensedyl,Pipolfen,Pipolphen,Promet,Prometazin,Promethazine Hydrochloride,Prothazin,Pyrethia,Remsed,Rumergan,Hydrochloride, Promethazine
D001831 Body Temperature The measure of the level of heat of a human or animal. Organ Temperature,Body Temperatures,Organ Temperatures,Temperature, Body,Temperature, Organ,Temperatures, Body,Temperatures, Organ
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

I J ten Berge, and K J Parlevliet, and S L Yong, and J Surachno, and J M Wilmink, and P T Schellekens
November 1990, Transplantation,
I J ten Berge, and K J Parlevliet, and S L Yong, and J Surachno, and J M Wilmink, and P T Schellekens
November 1987, Journal of immunology (Baltimore, Md. : 1950),
I J ten Berge, and K J Parlevliet, and S L Yong, and J Surachno, and J M Wilmink, and P T Schellekens
November 1996, Kidney international,
I J ten Berge, and K J Parlevliet, and S L Yong, and J Surachno, and J M Wilmink, and P T Schellekens
November 1987, European journal of immunology,
I J ten Berge, and K J Parlevliet, and S L Yong, and J Surachno, and J M Wilmink, and P T Schellekens
September 1996, Clinical and experimental immunology,
I J ten Berge, and K J Parlevliet, and S L Yong, and J Surachno, and J M Wilmink, and P T Schellekens
February 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
I J ten Berge, and K J Parlevliet, and S L Yong, and J Surachno, and J M Wilmink, and P T Schellekens
January 1992, Journal of immunological methods,
I J ten Berge, and K J Parlevliet, and S L Yong, and J Surachno, and J M Wilmink, and P T Schellekens
August 2015, Journal of immunology (Baltimore, Md. : 1950),
I J ten Berge, and K J Parlevliet, and S L Yong, and J Surachno, and J M Wilmink, and P T Schellekens
July 1994, Scandinavian journal of immunology,
I J ten Berge, and K J Parlevliet, and S L Yong, and J Surachno, and J M Wilmink, and P T Schellekens
September 1999, Clinical and experimental immunology,
Copied contents to your clipboard!